Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burt Nabors

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
CNS Oncology|July 18, 2023
An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastomaGarni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, et al.
Clinical Case Reports|January 2, 2020
Cauda equina syndrome in an ovarian malignant-mixed müllerian tumor with leptomeningeal spreadJoshua D Bernstock, Stuart Ostby, Brandon Fox, et al.
Journal of Neuro-Oncology|March 26, 2014
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitroXiaosi Han, Rong Li, Wenbin Zhang, et al.
Neuro-Oncology|October 16, 2025
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant GliomasDavid Schiff, Xiaobu Ye, Jing Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
JAMA Network Open|November 25, 2025
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed GlioblastomaEmilie Le Rhun, Debaleena Sain, Sara C Erridge, et al.
Oncotarget|September 17, 2017
Implementation and utilization of the molecular tumor board to guide precision medicineShuko Harada, Rebecca Arend, Qian Dai, et al.
British Journal of Neurosurgery|June 8, 2023
Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical seriesSepideh Mokhtari, Noah C Peeri, Andre Beer-Furlan, et al.
JCO Clinical Cancer Informatics|September 23, 2021
Data Matching to Support Analysis of Cancer Epidemiology Among Veterans Compared With Non-Veteran Populations-An Exemplar in Brain TumorsChristine Woo, Gino N Cioffi, Taissa A Bej, et al.
Oncotarget|February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcomeMichael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
CNS Oncology|July 18, 2023
An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastomaGarni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, et al.
Clinical Case Reports|January 2, 2020
Cauda equina syndrome in an ovarian malignant-mixed müllerian tumor with leptomeningeal spreadJoshua D Bernstock, Stuart Ostby, Brandon Fox, et al.
Journal of Neuro-Oncology|March 26, 2014
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitroXiaosi Han, Rong Li, Wenbin Zhang, et al.
Neuro-Oncology|October 16, 2025
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant GliomasDavid Schiff, Xiaobu Ye, Jing Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
JAMA Network Open|November 25, 2025
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed GlioblastomaEmilie Le Rhun, Debaleena Sain, Sara C Erridge, et al.
Oncotarget|September 17, 2017
Implementation and utilization of the molecular tumor board to guide precision medicineShuko Harada, Rebecca Arend, Qian Dai, et al.
British Journal of Neurosurgery|June 8, 2023
Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical seriesSepideh Mokhtari, Noah C Peeri, Andre Beer-Furlan, et al.
JCO Clinical Cancer Informatics|September 23, 2021
Data Matching to Support Analysis of Cancer Epidemiology Among Veterans Compared With Non-Veteran Populations-An Exemplar in Brain TumorsChristine Woo, Gino N Cioffi, Taissa A Bej, et al.
Oncotarget|February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcomeMichael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Pageof 14